✦ LIBER ✦

Mitomycin, cisplatin, and vindesine followed by radiotherapy combined with cisplatin in stage III nonsmall cell lung cancer: long-term results

✍ Scribed by Martin Tejedor; Juan J. Valerdi; Rafael López; Miguel A. Domínguez; Fernando Arias; JoséJ. Illarramendi; Enrique Martínez

Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 357 KB
Volume: 31
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(94)00575-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two cycles of cisplatin-vindesine and ra

Two cycles of cisplatin-vindesine and radiotherapy for localized nonsmall cell carcinoma of the lung (stage III). Results of a prospective trial with 149 patients

✍ Jean-Marc Tourani; Jean-François Timsit; Corine Delaisement; Jean-Claude Balzon; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 551 KB

Results of a phase II concurrent chemora

Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer

✍ L.M. Chen; L. Ignacio; R. Jacobs; M. Kozloff; M. Telfer; R. Elahi; R. Evans; S. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

Induction chemotherapy employing dose-in

Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma

✍ Kenneth K. Ng; Mark G. Kris; Robert J. Ginsberg; Robert T. Heelan; Katherine M. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## BACKGROUND. Cisplatin-based induction chemotherapy before surgery or irradiation has improved the survival of patients with Stage III nonsmall cell lung carcinoma (NSCLC). Encouraged by earlier results with preoperative MVP (cisplatin [120 mg/m 2 or 25 mg/m 2 /week], vinblastine, and mitomycin)

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views